Friday, 3 June 2022

U.S. doctors urged to test for monkeypox, CDC says risk to public low

U.S. doctors urged to test for monkeypox, CDC says risk to public low

U.S. health officials on Friday urged doctors to test for monkeypox if they suspect cases, saying there may be community-level spread but that the overall public health risk remained low.

Bristol Myers boosts cancer drug portfolio with $4.1 billion Turning Point deal

Bristol Myers Squibb Co said on Friday it will acquire drug developer Turning Point Therapeutics Inc for $4.1 billion in cash to help bolster its arsenal of cancer drugs.

U.S. doctors urged to test for monkeypox, CDC says risk to public low

U.S. health officials on Friday urged doctors to test for monkeypox if they suspect cases, saying there may be community-level spread but that the overall public health risk remained low.

Test makers target monkeypox market as cases surge

Demand for tests will be a fraction of what it was for COVID, given monkeypox is not as transmissible nor as dangerous.

Iraq reports bird flu outbreak on poultry farm

Iraq has reported an outbreak of highly pathogenic H5N8 avian influenza, commonly called bird flu, on a farm southeast of Baghdad, the World Organisation for Animal Health (OIE) said on Friday.

Spain's monkeypox case tally rises to 186, Health Ministry says

Spanish health authorities reported 30 new cases of monkeypox on Friday, bringing the total tally of infections to 186, the highest of the current outbreak.

FACTBOX -Vaccines delivered under COVAX sharing scheme for poorer countries

June 3 (Reuters) - The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), has delivered 1.52 billion COVID-19 vaccine doses to 146 countries, GAVI data shows.

U.S. FDA flags risk of heart inflammation after Novavax COVID vaccine

The U.S. Food and Drug Administration hasraised concerns about a possible risk of heart inflammation from Novavax Inc's COVID-19 vaccine, even as the company's data showed it could reduce the chances of mild-to-severe disease.

J&J, AbbVie cancer drug significantly slows progression of rare lymphoma, study shows

Johnson & Johnson and AbbVie's big-selling leukemia drug Imbruvica in combination with standard treatment kept a rare type of non-Hodgkin lymphoma in check for more than two years longer than the standard regimen alone in older patients, according to data presented on Friday.

South Korea to lift quarantine requirement for non-vaccinated foreign arrivals

South Korea's prime minister on Friday said the country will lift its quarantine requirement for foreign arrivals without vaccination from June 8 and also start lifting aviation regulations imposed for international flights.

Related Videos

Monkeypox "will not be like COVID" - Spanish microbiologist

Monkeypox can be contained if we act now: WHO

N.Korea reports more deaths amid COVID lockdown